KOSPI 10,000: Is the Korea Discount Finally Over?

As KOSPI breaks through 8,000 and races toward 10,000, many market participants ask: is the Korea Discount finally over? Value-up programs, commercial law reform debates, activist funds gaining ground — on the surface, everything seems to have changed.

But an absolute index level rising and a structural valuation discount closing are entirely different stories.

As of end-2024, KOSPI's PBR stands at approximately 0.98x. Over the same period, the S&P 500 trades at 4.8x book and TOPIX at 1.58x. Even as KOSPI races toward 10,000, Korean equities still trade at a discount to book value.

This is the critical point: KOSPI's rally is driven primarily by Samsung Electronics and SK Hynix, which together represent roughly 20–25% of KOSPI market cap. The HBM (High Bandwidth Memory) supercycle driven by AI demand lifted the index. This is EPS expansion, not multiple expansion — earnings went up; the market didn't start valuing Korean stocks more highly.

Activist investing is a strategy of acquiring a stake in a company and then applying direct pressure on management to drive change. In the US, it evolved from the corporate raider era of the 1980s into a sophisticated hedge fund-led practice post-2000s. Brav et al. (2008) found that activist campaigns generated average abnormal returns of approximately 7% in the year following announcement.

Many causes are cited for the Korea Discount: geopolitical risk (North Korea factor), low dividend payout ratios, complex circular ownership structures — all real factors. But they all converge on one fundamental incentive structure.

Controlling families have no financial reason to push stock prices higher.

The inheritance tax paradox: Korea's top inheritance tax rate is 50%. Add the 20% surcharge for the largest shareholder in listed large companies, and the effective rate reaches 60% — effectively the highest in the OECD.

The critical issue is the calculation basis. Inheritance tax on shares is assessed at market price. From the controlling family's perspective, a rising stock price means an exploding future inheritance tax burden. Minimizing dividends, avoiding shareholder-friendly policies, and being indifferent to stock price appreciation is entirely rational tax optimization.

Capital gains tax — another layer: Shareholders meeting the 'major shareholder' threshold (≥1% of a KOSPI stock or ≥KRW 5 billion in holdings) pay capital gains tax on stock sales (up to 25% for large-cap holdings). This has created a chronic year-end selling pressure dynamic as investors race to stay below the threshold. The government raised the threshold from KRW 1 billion to KRW 5 billion in late 2023 (applied to trades from 2024), easing some year-end pressure — but recurring debates over tax equity and political turnover keep this rule structurally uncertain.

Japan suffered the same affliction. In the early 2010s, TOPIX's average PBR was below 1.0x. The Nikkei index spent more than 25 years failing to recover its 1989 bubble peak of 38,957. Low dividends, circular cross-shareholdings (持ち合い), poor ROE — a mirror image of Korea's predicament.

Japan's prescription was market pressure, not legislation. Key milestones in the phased reform:

- 2014: FSA introduces Stewardship Code — mandatory disclosure of proxy voting
- 2015: TSE introduces Corporate Governance Code — recommends ≥2 independent directors
- March 2023: TSE requests listed companies with PBR below 1x to disclose plans to improve capital efficiency and stock price consciousness

There was no legal enforcement mechanism. Yet Japanese companies responded sharply — driven by cultural aversion to being named publicly and the timing coinciding with Warren Buffett's massive purchases of Japan's five major trading companies, signaling a flood of foreign capital.

The critical structural difference: Japan's reform worked faster for structural reasons. Founding family ownership concentration is lower than Korean chaebols, more companies were willing to unwind cross-holdings, and GPIF (Japan's national pension, ~¥200 trillion AUM) played an active stewardship role.

Most critically, Japan lacks Korea's 60% effective inheritance tax surcharge structure. Japan's top inheritance tax rate is 55%, but broad succession relief provisions apply for non-listed companies, and listed company owners have weaker tax incentives to suppress stock prices. This is the fundamental difference.

Korea's Value-up Program, benchmarked against Japan's TSE reform, was introduced in 2024. However, core legislative reform remains in a state of deadlock. Chaebols have mounted concentrated opposition lobbying, citing 'increased management uncertainty' and 'weakened global competitiveness.'

Korea's Value-up Program is the Korean version of Japan's TSE reform, but its effect remains limited so far. The number of disclosing companies grew in 2024, and share cancellation volumes hit record highs. Yet the proportion of KOSPI-listed companies trading below 1x book value remains around 50% — compared to Japan's reduction to the 40s within two years.

Looking at the fundamental metric, Korea's ROE sits at roughly 8–9%, below Japan's 10–11% and far below the US's 20%+. One core reason ROE is low is that earnings are retained on corporate balance sheets rather than returned to shareholders — which loops back to the tax structure.

KOSPI 10,000 does not signal the resolution of the Korea Discount. It reflects an earnings surge from the semiconductor supercycle. Activist funds can pressure, commercial law can be amended, and the National Pension Service can vote against management — but without changing the tax structure, the controlling family's fundamental incentive remains unchanged.

Japan achieved Nikkei 40,000 using only exchange guidelines and market pressure — no legislation needed. That success rested on a structural foundation where 'raising the stock price is not a tax bomb for the owner.'

Korea's Value-up and commercial law reform can produce results. But as long as the 60% effective inheritance tax rate and capital gains tax structure without step-up basis remain in place, these are likely to address symptoms rather than correct the underlying structure. At the next semiconductor cycle trough — that's when the real test begins.